ArticlePloS one2015

HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.

Marica Garziera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.